Other Events ·
Profound Medical presents five abstracts on TULSA-PRO system at Interventional MRI Symposium
PROFProfound Medical Corp.
Profound Medical Corp. issued a press release announcing that five abstracts related to its TULSA-PRO system were presented at the 15th Interventional MRI Symposium in Boston. The presentations highlight real-world performance data from the CARE Registry and Mayo Clinic, clinical differentiation results from the CAPTAIN randomized controlled trial comparing TULSA to robotic radical prostatectomy, and technical validation of the procedure on a lower-field-strength Siemens MRI platform. These findings aim to strengthen evidence supporting the system's safety, efficacy, and potential for broader adoption. Profound Medical Corp. is a commercial-stage medical device company that develops interventional MRI technologies, including the TULSA-PRO system for prostate ablation and Sonalleve for non-surgical therapy of various conditions.